Hypertonic Saline Dosing for Cerebral Edema
For cerebral edema, administer 3% hypertonic saline as an initial bolus of 5 mL/kg IV over 15 minutes, followed by a continuous maintenance infusion of 1 mL/kg per hour targeting a serum sodium level of 150-155 mEq/L. 1
Initial Bolus Dosing
- Give 5 mL/kg of 3% hypertonic saline IV over 15 minutes as the initial dose for acute cerebral edema or intracranial hypertension 1
- This equates to approximately 250 mL for a 50 kg patient or 350 mL for a 70 kg patient 1
- The bolus can be administered peripherally at rates up to 999 mL/hour safely without causing extravasation or phlebitis 2
Maintenance Infusion Protocol
- Start continuous infusion at 1 mL/kg per hour to maintain therapeutic effect 1
- Target serum sodium concentration of 150-155 mEq/L 1, 3
- Hold the infusion if sodium exceeds 155 mEq/L 1
- The absolute upper safety limit for serum osmolality is <320 mOsm/L 3
Critical Monitoring Requirements
Check electrolytes every 4 hours during active hypertonic saline therapy 1:
- Serum sodium
- Serum chloride
- Serum osmolality
This frequent monitoring is essential because hyperchloremic metabolic acidosis can develop, particularly in pediatric patients 4. If serum osmolality reaches ≥320 mOsm/kg or the osmolality gap is ≥40, hold the infusion immediately 1.
Comparative Efficacy: Hypertonic Saline vs Mannitol
At equiosmotic doses (approximately 250 mOsm), hypertonic saline and mannitol have comparable efficacy for reducing intracranial pressure 3, 5. However, hypertonic saline is superior in specific clinical contexts 3:
- Hypotension or hypovolemia: Hypertonic saline increases blood pressure and has minimal diuretic effect, whereas mannitol causes significant osmotic diuresis requiring volume compensation 3
- Hypernatremia: Choose mannitol when hypernatremia is already present 6
Hemodynamic Considerations
Maintain cerebral perfusion pressure (CPP) at 60-70 mmHg during osmotic therapy 3, 5. In hypotensive patients:
- Initiate aggressive fluid resuscitation with crystalloids before or concurrent with osmotic therapy 5
- Hypertonic saline is preferred over mannitol in the setting of systolic blood pressure <100 mmHg or mean arterial pressure <70 mmHg 3, 5
Administration Route
Central venous access is preferred but not required 7. Peripheral administration of 3% hypertonic saline is safe when:
- Using an 18-gauge or larger IV catheter 2
- Antecubital placement is preferred 2
- Monitoring for signs of phlebitis or extravasation 7, 2
- Rates up to 999 mL/hour have been administered peripherally without complications in emergency settings 2
Pediatric-Specific Dosing
The dosing algorithm is identical for pediatric patients 1:
- Initial bolus: 5 mL/kg of 3% saline IV over 15 minutes
- Maintenance: 1 mL/kg per hour
- Target sodium: 150-155 mEq/L
- Monitor electrolytes every 4 hours
Pediatric patients may be at higher risk for hyperchloremic metabolic acidosis, which occurred in 16% of pediatric patients in one series 4.
Duration of Therapy
Hypertonic saline can be continued for 4-25 days based on clinical need 8, 4. Target hypernatremia (150-155 mEq/L) is typically achieved within the first 24 hours in approximately 50% of patients, with 74% achieving target levels overall 8.
Common Pitfalls to Avoid
- Do not use hypertonic saline concentrations >3% for continuous infusions without specialized protocols; higher concentrations (23.4%) are reserved for single bolus doses in herniation emergencies 3
- Do not stop monitoring electrolytes after the first 24 hours; continue every 4-6 hours throughout therapy 1
- Do not allow serum sodium to exceed 155 mEq/L on maintenance infusion; hold the infusion and recheck labs 1
- Do not use in patients with severe hypernatremia (>155 mEq/L) at baseline; consider mannitol instead 6
Adjunctive Measures
Hypertonic saline should be combined with 1:
- Head of bed elevation to 30 degrees
- Hyperventilation targeting PaCO2 of 30-40 mmHg during acute management
- High-dose corticosteroids for grade 4 encephalopathy syndromes
- Daily CT imaging to monitor for rebound cerebral edema